{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG|Designated/Withdrawn" in comments (approximate match)
Status:
Investigational
Source:
NCT02890368: Phase 1 Interventional Terminated Solid Tumors
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02345070: Phase 2 Interventional Completed Idiopathic Pulmonary Fibrosis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT02472145: Phase 2/Phase 3 Interventional Completed Leukemia, Myeloid, Acute
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02605525: Phase 2 Interventional Withdrawn Immunoglobulin A Nephropathy
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03631706: Phase 3 Interventional Completed Non-small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02754076: Phase 1/Phase 2 Interventional Completed MPS III B
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00244257: Phase 1 Interventional Terminated Idiopathic Thrombocytopenic Purpura
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03512340: Phase 1 Interventional Completed Advanced Solid Cancers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01222117: Phase 2 Interventional Completed Acute Peripheral Arterial Occlusion
(2010)
Source URL:
Class:
PROTEIN